Health and Human Services Secretary Robert F. Kennedy's newly appointed CDC vaccine advisory panel reportedly has seven ...

Shares of Novavax Inc. NVAX rose 2.85% to $6.49 Tuesday, on what proved to be an all-around positive trading session for the ...

Novavax Inc. closed 64.57% short of its 52-week high of $17.81, which the company achieved on July 26th.

Shares of San Diego-based Cidara Therapeutics Inc. (NASDAQ:CDTX) were trading at $40.41, up $19.39, or 92%, on positive top-line results from its randomized, double-blind, placebo-controlled phase IIb ...

Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...

Novavax has experienced a notable decline in its stock price over the past week, dropping by 8.82%. This downturn comes amidst a challenging landscape for the company, as Citi ini ...

Novavax (NVAX) concluded the recent trading session at $6.41, signifying a +1.75% move from its prior day's close.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Get the latest news on Crescent Biopharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Crescent Biopharma performance ...

Shares of Novavax Inc. NVAX slid 7.68% to $6.49 Tuesday, on what proved to be an all-around poor trading session for the ...